kaal:position:2026-07-31-963

Author Correction: Dynamic regulation of hypoxia-inducible factor-1α activity is essential for normal B cell development should be assessed against Kaal's source-bound claim that Because quarterly Form PF filing costs roughly $10,000 per reporting fund, the $1.5 billion threshold that triggers quarterly filing gives advisers a direct cost reason to factor that threshold into the AUM decision. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

advisers approaching $1.5 billion in AUM
per reporting fund cost basis
External evidence level: metadata only.
Mapping review tier: moderate-confidence claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

Author Correction: Dynamic regulation of hypoxia-inducible factor-1α activity is essential for normal B cell development

Scholarly basis

kaal:claim:2739479-031
Wulf A. Kaal, The Post Dodd-Frank Act Evolution of the Private Fund Industry Comparative Evidence from 2012 and 2 (2016). SSRN: https://ssrn.com/abstract=2739479
Source PDF sha256: b2e7b81a16ab01c73478b62e85068f9dadc5cdd18427241e8bc5e8216a967730

Evidence and mapping

Evidence: metadata only
Review tier: moderate-confidence claim review
Mapping confidence: 0.3787
Mapping ambiguous: true

Topics

private-fundsdisclosurecompliancedynamic-regulation

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0004 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: ae35e0390bb4e114d189185539438c509ccdd5052beb73d582c44d0fc255f344
curl -s https://wulfkaal.github.io/positions/2026-07-31-963.md | sha256sum